The Journal of Targeted Therapies in Cancer
August 2013
Volume: 1
Issue: 8
April 2013
Volume: 1
Issue: 6
February 2013
Volume: 1
Issue: 5
June 2013
Volume: 1
Issue: 7
November 2012
Volume: 1
Issue: 4
September 2012
Volume: 1
Issue: 3
June 2012
Volume: 1
Issue: 2
March 2012
Volume: 1
Issue: 1
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Approves Iberdomide, the First CELMoD for Relapsed/Refractory Multiple Myeloma
2
How the Immune System Drives Nerve Growth in TNBC
3
AMH Testing Predicts Chemotherapy Benefit in RxPONDER Breast Cancer
4
FAQ: When and How to Discontinue Lenalidomide Maintenance in Multiple Myeloma
5